EUVIMEDEUVIMED entdecken
Crossref

Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape

Patrick J. Hensley, Niyati Lobo, Kelly K. Bree, Wei Shen Tan, Paolo Gontero, Stephen B. Williams, Charles C. Guo, Gianluca Giannarini, Lars Dyrskjøt, Ashish M. Kamat

Société Internationale d’Urologie Journal · 15.07.2022 · 3 (4) · 245-257

DOI: 10.48083/rvzv1144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Société Internationale d’Urologie Journal, online erschienen am 15.07.2022. Verfasst von Patrick J. Hensley und 9 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer (BC) is a heterogeneous disease with prognosis and therapeutic strategies highly dependent on tumor grade and stage. Predictive biomarkers of therapeutic response have been studied to guide selection of intravesical and/or systemic therapy. A predictive biomarker is measured before the start of treatment and provides information on the likelihood of response to a specific therapy. Many candidate predictive biomarkers for BC have been identified, but few have been rigorously validated or distinguished from simply having treatment-agnostic prognostic capacity. Identifying predictive biomarkers tailored to therapeutic mechanism of action has considerable implications for the sequencing of therapies, as well as bladder preservation strategies in advanced disease states. We evaluate predictive tissue-based, urine-based, and serum-based biomarkers across the spectrum of non–muscle-invasive and muscle-invasive BC and preview predictive biomarkers for emerging targeted therapies.

Zitieren

APA

Hensley, P. J., Lobo, N., Bree, K. K., Tan, W. S., Gontero, P., Williams, S. B., Guo, C. C., Giannarini, G., Dyrskjøt, L., & Kamat, A. M. (2022). Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale d’Urologie Journal, 3(4), 245-257. https://doi.org/10.48083/rvzv1144

Vancouver

Hensley PJ, Lobo N, Bree KK, Tan WS, Gontero P, Williams SB, et al. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale d’Urologie Journal. 2022;3(4):245-257. doi:10.48083/rvzv1144

BibTeX
@article{Hensley2022,
  author = {Hensley, Patrick J. and Lobo, Niyati and Bree, Kelly K. and Tan, Wei Shen and Gontero, Paolo and Williams, Stephen B. and Guo, Charles C. and Giannarini, Gianluca and Dyrskjøt, Lars and Kamat, Ashish M.},
  title = {Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape},
  journal = {Société Internationale d’Urologie Journal},
  year = {2022},
  volume = {3},
  number = {4},
  pages = {245--257},
  doi = {10.48083/rvzv1144}
}
Kostenlos starten →